Form 4: VolitionRX Director Kim Nguyen Reports Acquisition of 8,011 Shares of Common Stock

Director Kim Nguyen reports acquiring 8,011 shares of VolitionRX common stock on June 1, 2024, through restricted stock units (RSUs) in lieu of cash compensation.

Summary

• On June 4, 2024, Kim Nguyen, a director of VolitionRX Ltd, filed a Form 4 with the SEC.
• The report details a transaction on June 1, 2024, where Nguyen acquired 8,011 shares of VolitionRX common stock.
• These shares were obtained through restricted stock units (RSUs) awarded under the company's 2015 Stock Incentive Plan.
• The RSUs were granted in lieu of cash compensation that would have otherwise been owed to Nguyen.
• The RSUs vest in three installments of 2,671, 2,670, and 2,670 units on June 1, 2024, July 1, 2024, and August 1, 2024, respectively, with further time-based vesting on May 1, 2025, subject to continued service.
• Following the transaction, Nguyen directly owns 53,697 shares of common stock and indirectly owns 30,556 shares through a spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a stock transaction. The acquisition of shares by a director is generally viewed as a positive signal, but the document itself is purely informational.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or future prospects, focusing instead on the details of the stock transaction.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't provide specific insights into the broader industry trends or competitive landscape for VolitionRX.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates